OpenBilldrug price receipt

NADAC week of 2026-10-14

ALMOTRIPTAN MALATE 12.5 MG TAB

For 30 tablets

Pharmacies pay

$505.70 filed

30 × $16.85661 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$557.78 filed

30 × $18.59267 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.1× estimated

Medicare paid 1.1× what pharmacies pay.

Part D averages every strength and form sold under “Almotriptan Malate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$586.56 estimated

$505.70 + $75.86 (15%) + $5.00 fee per fill = $586.56

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ALMOTRIPTAN MALATE 12.5 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “almotriptan” and “almotriptan malate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as tablet, film coated and its route as oral.

Its labelers, the companies named on the label, are Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Ajanta Pharma USA Inc.

FDA’s Established Pharmacologic Class for it is Serotonin-1b and Serotonin-1d Receptor Agonist.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes); the FDA directory lists 3 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $505.70 for 30 tablets (30 × $16.85661 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 6 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with ALMOTRIPTAN MALATE 12.5 MG TAB.

ProductPharmacies pay per unitMedicare per unit
ALMOTRIPTAN MALATE 6.25 MG TAB
generic · tablet, film coated
$16.50912 per EA filed
eff. 2026-09-23
$18.59267 per EA filed
Part D 2024 average
ALMOTRIPTAN MALATE 12.5 MG TAB this page
generic · tablet, film coated
$16.85661 per EA filed
eff. 2026-09-23
$18.59267 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $16.85661 per EA filed.

Of the 28 other products in FDA’s Serotonin-1b and Serotonin-1d Receptor Agonist class priced per EA, 9 have a higher middle NADAC price and 19 a lower one. The one in the middle is ZOLMITRIPTAN 2.5 MG ODT, at $2.06825 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $557.78 for 30 tablets, at an average of $18.59267 per EA in 2024 (2024-01-01 to 2024-12-31) for “Almotriptan Malate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 5,489 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

2 of the product’s 6 NDCs have this Medicare figure; the other 4 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ALMOTRIPTAN MALATE 12.5 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Almotriptan Malate / Almotriptan Malate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.